Effects of topical application of 10,000 IU heparin on patients with perineal dermatitis and second-degree burns treated in a public pediatric hospital.

[1]  S. Costa.  Why gram-negative bacteria are the major cause of bacterial infection among hematology patients in Brazil , 2009 .

[2]  R. Bartlett,et al.  A heparin-coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit. , 2008, Artificial organs.

[3]  J. Rak,et al.  Heparin and angiogenesis: size matters! , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[4]  S. H. Mandelbaum,et al.  Cicatrization: current concepts and auxiliary resources - Part II , 2003 .

[5]  Maria Helena Sant Ana Mandelbaum,et al.  Cicatrization: current concepts and auxiliary resources - Part II , 2003 .

[6]  Denise de Andrade,et al.  Curativo do paciente queimado: uma revisão de literatura , 2003 .

[7]  J. Revuz,et al.  [Pain management and the use of analgesics in dermatology]. , 2002, Annales de dermatologie et de venereologie.

[8]  K. Baldwin.  Incidence and Prevalence of Pressure Ulcers in Children , 2002, Advances in skin & wound care.

[9]  A. Nagler,et al.  Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  J. Saliba,et al.  Heparin in the treatment of burns: a review. , 2001, Burns : journal of the International Society for Burn Injuries.

[11]  M. Sans,et al.  Heparin attenuates TNF-α induced inflammatory response through a CD11b dependent mechanism , 2000, Gut.

[12]  Kido,et al.  Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  T. Rosengart,et al.  Therapeutic angiogenesis: a comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin. , 1997, Journal of vascular surgery.

[14]  M C Logsdon,et al.  The Neonatal Skin Risk Assessment Scale for predicting skin breakdown in neonates. , 1997, Issues in comprehensive pediatric nursing.

[15]  H. Viinamäki,et al.  Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis. , 1993, Psychotherapy and psychosomatics.

[16]  K. Norrby.  Heparin and angiogenesis: a low-molecular-weight fraction inhibits and a high-molecular-weight fraction stimulates angiogenesis systemically. , 1993, Haemostasis.

[17]  K. Norrby,et al.  Heparin enhances angiogenesis by a systemic mode of action. , 1992, International journal of experimental pathology.

[18]  R. Baer.  Papaverine therapy in atopic dermatitis. , 1985, Journal of the American Academy of Dermatology.

[19]  M. Dahl.  Staphylococcus aureus and atopic dermatitis. , 1983, Archives of dermatology.

[20]  M. Saliba,et al.  Large burns in humans. Treatment with heparin. , 1973, JAMA.

[21]  M. Saliba.  Heparin efficacy in burns. II. Human thermal burn treatment with large doses of topical and parenteral heparin. , 1970, Aerospace medicine.

[22]  L. Ferreira,et al.  Hemicellulose dressing for skin lesions caused by herpes zoster in a patient with leukemia-an alternative dressing. , 2009, Wounds : a compendium of clinical research and practice.

[23]  S. Smorenburg.  Inhibition of angiogenesis with heparin? , 2001, Haemostasis.

[24]  J. Hirsh,et al.  Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1995, Chest.

[25]  Robert C. Wolpert,et al.  A Review of the , 1985 .